摘要：In many vaccine efficacy studies where the endpoint is a rare infection/disease event, an event-driven design is commonly used for testing the hypothesis that study vaccine lowers the risk of the event. Uncertainty of the incidence rate has a large impact on the sample size and study duration. To mitigate the risk of running a potentially large, long-duration efficacy trial with an uncertain event rate, we propose a two-stage adaptive design strategy with interim analyses to allow evaluation of study feasibility and sample size adaptation. During Stage I, a modest number of subjects will be enrolled and the feasibility of the study will be evaluated based on the incidence rate observed. If the feasibility of the study is established, at the end of Stage I a formal interim analysis will be performed, with a potential sample size adaptation based on the conditional rejection probability approach. The operating characteristics of this design are evaluated via simulation.
